- Sumitomo Pharma (Austin, TX)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment....urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in… more
- Sumitomo Pharma (Austin, TX)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment....urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in… more
- Sumitomo Pharma (Austin, TX)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment....urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in… more
- Sumitomo Pharma (Austin, TX)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment....urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in… more
- Catholic Health Initiatives (Houston, TX)
- …Perfusion. + New grads must have provisional license contingent on passing ABCP exam. Must test and pass the exam within 12 months of hire to be qualified for CCP ... the patient care requirements and treatment necessary for ECMO, HIPEC, Cell Savers and cardiopulmonary bypass/assistance before, during or after surgery. Operate… more
- Sumitomo Pharma (Austin, TX)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment....urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in… more
- MD Anderson Cancer Center (Houston, TX)
- …resistance in breast cancer patients using novel therapeutics (ie drugs targeting different cell cycle pathways) . Develops new strategies and tools to define the ... for digital manipulation and hand to eye coordination for manipulation of animals, test tubes, and other laboratory devices. Must work with animals. *EDUCATION *… more
- Sumitomo Pharma (Austin, TX)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment....urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in… more
- Sumitomo Pharma (Austin, TX)
- …needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the US, Canada, and ... in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment....urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in… more
- MD Anderson Cancer Center (Houston, TX)
- …team of microbiologists, synthetic biologists, and engineers dedicated to developing microbial cell therapies (MCTs) for cancer treatment. Our long-term goal is to ... context. We use insights from tumor microbiome profiling to guide engineering efforts and test these strains in vitro and in preclinical models of solid tumors. We… more